28 April 2022
Arkle Resources PLC
("Arkle" or the "Company")
Exercise of Warrants
Arkle announces that, pursuant to the receipt of warrant conversion notices, it has issued 9,320,000 ordinary shares of EUR0.0025 each ("Ordinary Shares") at the exercise price of 0.5 pence per share ("New Shares").
Application has been made for the New Shares, which will rank pari passu with the existing Ordinary Shares, to be admitted to trading on AIM and it is expected that this will take place at 8.00 a.m. on or around 5 May 2022 ("Admission"). The proceeds of the exercise of GBP 46,600 will be used for additional working capital.
Total Voting Rights
Following Admission, Arkle will have 345,382,426 Ordinary Shares in issue which will also represent the total number of voting rights in the Company. The above figure should be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.
This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.
The person who arranged for the release of this announcement on behalf of the Company was Jim Finn, Director.
A copy of this announcement is available on the Company's website, at www.arkleresources.com
ENDS
Enquiries:
Arkle Resources PLC
John Teeling, Chairman +353 (0) 1 833 2833
Jim Finn, Finance Director +353 (0) 1 833 2833
SP Angel Corporate Finance LLP
Nominated Adviser & Joint Broker
Matthew Johnson/Adam Cowl +44 (0) 203 470 0470
First Equity Limited
Joint Broker
Jason Robertson +44 (0) 207 374 2212
BlytheRay +44 (0) 207 138 3204
Megan Ray
Rachael Brooks
Teneo
Luke Hogg +353 (0) 1 661 4055
Ciara Wylie +353 (0) 1 661 4055
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.